首页> 外文OA文献 >Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

【2h】

Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

机译：中性粒细胞淋巴细胞比例是患有局部晚期（IIIA和IIIB）非小细胞肺癌的患者的预后标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Katherine A. Scilla; Søren M. Bentzen; Vincent K. Lam; Pranshu Mohindra; Elizabeth M. Nichols; Melissa A. Vyfhuis; Neha Bhooshan; Steven J. Feigenberg; Martin J. Edelman; Josephine L. Feliciano;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy [J] . Scilla Katherine A., Bentzen Soren M., Lam Vincent K., The oncologist . 2017,第6期

机译：中性粒细胞淋巴细胞比例是患有局部晚期（IIIA和IIIB）非小细胞肺癌的患者的预后标志物
2. Neutrophila??Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Nona??Small Cell Lung Cancer Treated with Combined Modality Therapy [J] . Katherine A. Scilla, S??ren M. Bentzen, Vincent K. Lam, The oncologist . 2017,第6期

机译：中性粒细胞??淋巴细胞比率是局部晚期（IIIA和IIIB期）Nona ??小细胞肺癌患者联合治疗的预后标志物
3. Dynamic Neutrophil to Lymphocyte Ratio is a Useful Prognostic Factor in Locally Advanced Non-small Cell Lung Cancer Patients Treated with Thoracic Radiation Therapy: A Retrospective Study [J] . Dong X., Wang L., Bi N., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：动态中性粒细胞与淋巴细胞比例是临床治疗临床治疗局部晚期非小细胞肺癌患者的有用预后因素：回顾性研究
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy [O] . Katherine A. Scilla, Søren M. Bentzen, Vincent K. Lam, 2017

机译：中性粒细胞-淋巴细胞比率是联合疗法联合治疗局部晚期（IIIA和IIIB期）非小细胞肺癌患者的预后指标
7. Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on Metastases [O] . H. Nonaka, H. Onishi, Z. Chen, 2019

机译：患有立体定向体放射治疗阶段I期非小细胞肺癌患者预处理中性粒细胞对淋巴细胞比的预后价值：聚焦转移的分析

Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅